Pular para o conteúdo

Small Vessels, Big Questions – Biomarkers, Cerebrovascular Autoregulation and Emerging Therapeutic Targets in Cerebral Small Vessel Disease

28 de julho de 2026 · 12 min

Notas do episódio

Cerebral small vessel disease is increasingly recognised as one of the leading causes of stroke, cognitive impairment and dementia worldwide. Despite its enormous clinical impact, disease-modifying therapies remain limited.

In this episode of Voice of Stroke, we explore how advances in biomarker discovery and cerebrovascular physiology are reshaping our understanding of cSVD and identifying promising new therapeutic targets.

This episode discusses:

  • The global burden of cerebral small vessel disease
  • Cerebrospinal fluid and blood biomarkers for disease characterisation and progression
  • Cerebral autoregulation as an emerging physiological biomarker
  • The potential role of phosphodiesterase-5 inhibitors and other therapies targeting cerebral vascular function

Featuring discussion of recent research published in:

  • International Journal of Stroke
  • Nature Aging
  • Alzheimer's Research & Therapy
  • Frontiers in Neurology

Written by: Annemijn Algra, Voice of Stroke Podcast Editor, and Linxin Li, Voice of Stroke Editor-in-Chief.

Read the full transcript

References

1. Lam BYK, et al. Global burden of cerebral small vessel disease determined from large MRI studies: A systematic review and meta-analysis. International Journal of Stroke. 2026.

2. Hristovska I, et al. Identification of distinct and shared biomarker panels in different manifestations of cerebral small-vessel disease through proteomic profiling. Nature Aging. 2026.

3. Yang D, et al. Plasma extracellular vesicle proteins biomarker for cerebral small vessel disease related cognitive impairment. Alzheimer's Research & Therapy. 2026.

4. Webb AJS, et al. The role of impaired autoregulation in cerebral small vessel disease and vascular cognitive impairment. International Journal of Stroke. 2026.

5. Yan L, et al. Phosphodiesterase-5 inhibitors for cerebral small vessel disease-related ischemic stroke and cognitive decline: Systematic review and meta-analysis. Frontiers in Neurology. 2026.

Todos os episódios de ESO Voice of Stroke

Configurações

Exibição

Idioma

Define quais estações você vê primeiro na página inicial.

Histórico

As rádios e episódios ouvidos recentemente e suas últimas buscas ficam só neste navegador.

Avisos

Um aviso rápido quando um podcast que você segue tem um episódio novo. Desative podcasts individuais pelo sino na página deles.

Conta

Salve favoritos – no app e no site.

Atalhos de teclado

/
Abrir busca
Espaço
Reproduzir ou pausar
← →
No player: voltar 15 s, avançar 30 s (episódios) · na fileira: próximo bloco
↑ ↓
Na fileira: alvo dentro do bloco
Home / End
Na fileira: primeiro ou último bloco
Esc
Fechar janela ou menu
?
Esta visão geral
Tocando agora

Ir para a estação

A seguir

    Adicione episódios com “A seguir” – eles tocam depois do episódio atual.